Cancer Research Audrey Hepburn  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 1038, February 1, 2007. doi: 10.1158/0008-5472.CAN-06-2295
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zins, K.
Right arrow Articles by Aharinejad, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zins, K.
Right arrow Articles by Aharinejad, S.

Cell, Tumor, and Stem Cell Biology

Colon Cancer Cell–Derived Tumor Necrosis Factor-{alpha} Mediates the Tumor Growth–Promoting Response in Macrophages by Up-regulating the Colony-Stimulating Factor-1 Pathway

Karin Zins1, Dietmar Abraham1, Mouldy Sioud2 and Seyedhossein Aharinejad1

1 Laboratory for Cardiovascular Research, Department of Anatomy and Cell Biology, Vienna Medical University, Vienna, Austria and 2 Department of Immunology, Molecular Medicine Group, Norwegian Radium Hospital, Oslo, Norway

Requests for reprints: Seyedhossein Aharinejad, Laboratory for Cardiovascular Research, Department of Anatomy and Cell Biology, Vienna Medical University, Waehringerstrasse 13, A-1090 Vienna, Austria. Phone: 431-4277-61119; Fax: 431-4277-61120; E-mail: seyedhossein.aharinejad{at}meduniwien.ac.at.

The interplay between malignant and stromal cells is essential in tumorigenesis. We have previously shown that colony-stimulating factor (CSF)-1, matrix metalloprotease (MMP)-2, and vascular endothelial growth factor (VEGF)-A production by stromal cells is enhanced by CSF-1–negative SW620 colon cancer cells. In the present study, the mechanisms by which colon cancer cells up-regulate host factors to promote tumorigenesis were investigated. Profiling of tumor cell cytokine expression in SW620 tumor xenografts in nude mice showed increased human tumor necrosis factor (TNF)-{alpha} mRNA expression with tumor growth. Incubation of macrophages with small interfering (si) RNAs directed against TNF-{alpha} or TNF-{alpha}–depleted SW620 cell conditioned medium versus SW620 cell conditioned medium failed to support mouse macrophage proliferation, migration, and expression of CSF-1, VEGF-A, and MMP-2 mRNAs. Consistent with these results, human TNF-{alpha} gene silencing decreased mouse macrophage TNF-{alpha}, CSF-1, MMP-2, and VEGF-A mRNA expression in macrophages cocultured with human cancer cells. In addition, inhibition of human TNF-{alpha} or mouse CSF-1 expression by siRNA reduced tumor growth in SW620 tumor xenografts in mice. These results suggest that colon cancer cell–derived TNF-{alpha} stimulates TNF-{alpha} and CSF-1 production by macrophages, and that CSF-1, in turn, induces macrophage VEGF-A and MMP-2 in an autocrine manner. Thus, interrupting tumor cell–macrophage communication by targeting TNF-{alpha} may provide an alternative therapeutic approach for the treatment of colon cancer. [Cancer Res 2007;67(3):1038–45]




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
X. Q. Lun, J.-H. Jang, N. Tang, H. Deng, R. Head, J. C. Bell, D. F. Stojdl, C. L. Nutt, D. L. Senger, P. A. Forsyth, et al.
Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide
Clin. Cancer Res., April 15, 2009; 15(8): 2777 - 2788.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
X.-D. Zhu, J.-B. Zhang, P.-Y. Zhuang, H.-G. Zhu, W. Zhang, Y.-Q. Xiong, W.-Z. Wu, L. Wang, Z.-Y. Tang, and H.-C. Sun
High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma
J. Clin. Oncol., June 1, 2008; 26(16): 2707 - 2716.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Fichtner-Feigl, M. Terabe, A. Kitani, C. A. Young, I. Fuss, E. K. Geissler, H.-J. Schlitt, J. A. Berzofsky, and W. Strober
Restoration of Tumor Immunosurveillance via Targeting of Interleukin-13 Receptor-{alpha}2
Cancer Res., May 1, 2008; 68(9): 3467 - 3475.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.